SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors weigh strong cloud infrastructure growth against concerns over high capital expenditures and a previously disclosed stock-trading plan by Chairman Larry Ellison. The conversation is largely divided between bullish investors who view the recent price drop as a buying opportunity given the company's AI-driven backlog and bears who are concerned about debt levels and potential equity dilution.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

The conversation surrounding QMCO is largely driven by concerns over a significant share overhang from pre-existing institutional investors and anticipated dilution. While some traders view the company's autonomous data management initiatives as a positive catalyst, the dominant sentiment remains skeptical, with many focusing on the disconnect between the stock's valuation and its financial performance.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Traders are intensely debating the stock's recent volatility and downward pressure following earnings, with many viewing the dip as a significant buying opportunity for a company with strong growth potential in AI connectivity. While some investors express frustration over the lack of sustained recovery and recent S&P 500 inclusion speculation that failed to materialize, a large portion of the community remains bullish, citing strong fundamentals and long-term infrastructure demand.

the cat on Base  community-run home for $BASECAT

Basecat

Basecat is experiencing high volatility as traders debate whether the recent price decline represents a buying opportunity or a typical pump-and-dump cycle common with new exchange listings. While some participants are aggressively accumulating the token in anticipation of a reversal and long-term growth, others express skepticism and caution regarding its stability.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is experiencing high volatility as traders react to shifting developments in U.S.-Iran relations, particularly fluctuations in conflict levels and ongoing negotiations regarding shipping access in the Strait of Hormuz. Community sentiment remains polarized, with some traders betting on further supply disruptions and others anticipating a bearish reversal as global oil production ramps up.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as it hits all-time highs, fueled by positive analyst price target increases and strong investor sentiment surrounding cybersecurity as a critical defense against AI-driven threats. Traders are closely monitoring the stock ahead of its upcoming earnings report, with some debating whether the significant rally and elevated valuation metrics are justified.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as traders discuss potential catalysts including upcoming medical conferences in Seoul and New York, speculation about government funding for the company's Dunkirk manufacturing facility, and the broader clinical application of its Anktiva treatment. The conversation remains heavily focused on the company's competitive position against established oncology therapies, with many in the community expressing frustration over recent price volatility and sustained short interest.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as traders closely monitor progress for its lead oncology asset, ivonescimab, particularly following updated overall survival results from the Phase III HARMONi trial and ahead of a key regulatory decision. Community conversation is driven by optimism regarding the drug's potential to compete with established treatments and positive insider buying activity, despite some uncertainty and debate over regulatory pathways.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant investor attention as traders debate whether the stock's recent decline is a manipulated shakeout by institutional players or a broader sector rotation away from healthcare. While some express frustration over the ongoing selloff, many investors remain bullish, pointing to strong earnings fundamentals, increased share buyback plans, and historical midterm year performance as reasons to hold or accumulate shares.

Cash Cat

Cash Cat is experiencing significant price volatility and downward pressure, with traders debating whether the asset is a long-term "conviction play" in the Robinhood ecosystem or a failing "pump and dump" scheme. While some investors remain bullish, citing utility and upcoming catalysts, others are expressing frustration over the coin's inability to hold gains and the impact of perceived market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Keymed Biosciences Announces 2026 H1 Results and Business Updates

Keymed Biosciences Announces 2026 H1 Results and Business Updates Keymed Biosciences Announces 2026 H1 Results and Business Updates PR Newswire CHENGDU, China, Aug. 20, 2026 CHENGDU, China, Aug. 20, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim...

Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline

Gilead Sciences, Inc. (Nasdaq: GILD) and Lakefront Biotherapeutics NV (Euronext & Nasdaq: LKFT) today announced the successful completion of the previously announced acquisition of Ouro Medicines to advance T cell engager therapies for autoimmune diseases. This press release features multimedia...

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Lakefront Biotherapeutics NV - ADR

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$26.81
Prev Close	$26.81
Open	$27.30
Dividend Yield	0.00%
50-Day Moving Average	$28.50
Beta	0.52
Avg. Volume	269,078.84
PE Ratio	2.55

52-Week High	$37.78
52-Week Low	$25.68
Market Capitalization	$1.76B
EPS (Annual)	$5.50
Price to Book	0.47
Revenue Per Employee	$2.78M

Feed

News

Sentiment

Earnings

Fundamentals

Info

LKFT Fundamentals